Atlas Trials

Tdap and Biomarkers of Alzheimer's Disease

Clinical trial NCT05183516 · UNKNOWN

Trial details

NCT number
NCT05183516
Sponsor
Mindful Diagnostics and Therapeutics, LLC
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease, Late Onset
Start date
2023-05-01
Primary completion
2023-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.